Labcorp Holdings Inc. Officer Receives Grant of 3,000 Restricted Stock Units
LABCORP HOLDINGS INC.
Subscribe to track LH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Labcorp Holdings Inc. ($LH) Form 4 Alert Insider: Brian J. Caveney (EVP, Pres of BLS, CMO & CSO) Transaction: Grant/Award of 3,000 Restricted Stock Units (RSUs) at $0.00 Date: September 1, 2026 Post-Transaction Holdings: 7,170 RSUs Significance: Low (Standard equity incentive award)
Comprehensive Analysis
Transaction Overview
On September 1, 2026, Brian J. Caveney, Executive Vice President, President of BLS, Chief Medical Officer, and Chief Scientific Officer at Labcorp Holdings Inc. ($LH), was awarded 3,000 Restricted Stock Units (RSUs) as part of standard equity compensation.
Key Details
- Security: Restricted Stock Units
- Transaction Code:
A(Grant/Award) - Number of Units: 3,000
- Price per Share: $0.00
- Vesting Terms: The RSUs vest in three equal annual installments beginning on September 1, 2027.
- Post-Transaction Holdings: 7,170 RSUs held directly.
Market & Insider Context
This Form 4 represents a routine annual or milestone equity compensation grant rather than an open-market transaction. Because no capital was deployed or shares liquidated in the open market, this transaction carries low trading significance for market participants.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.